This inventor holds 1 USPTO granted patent. Top assignee: Mymetics Corporation. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: The Innovations of Marc P Girard
Introduction
Marc P Girard is a notable inventor based in Lyons, France. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides related to HIV-1.
Latest Patents
Girard holds a patent for a "Soluble and stabilized trimeric form of gp41 polypeptides." This invention concerns a modified polypeptide that contains an immunodominant region and the connecting loop between the N- and C-helices of the gp41 ectodomain of HIV-1. The connecting loop includes a linker fragment that maintains the native conformation of the interaction between the N- and C-helices while providing sufficient hydrophilicity to ensure a soluble and stable trimeric form of the modified polypeptide.
Career Highlights
Marc P Girard is associated with Mymetics Corporation, where he continues to work on innovative solutions in the field of immunology. His research focuses on enhancing the stability and efficacy of polypeptides, which can have significant implications for vaccine development.
Collaborations
Girard has collaborated with notable colleagues such as Sylvain Fleury and Marie-Gaëlle Roger. Their combined expertise contributes to the advancement of research in their field.
Conclusion
Marc P Girard's work exemplifies the innovative spirit in biotechnology, particularly in the fight against HIV-1. His contributions through patents and collaborations highlight the importance of research in developing effective medical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile